UPDATE: Citigroup Downgrades Humana on Uncertainty Ahead

In a report published Thursday, Citigroup analyst Carl McDonald downgraded Humana (NYSE: HUM ) from Buy to Neutral, but raised the price target from $87.00 to $95.00. In the report, Citigroup noted, “We think there's upside to Humana's 2013 guidance, but so does everyone else. For 2014, the view is murkier.